Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
2.595 USD | +2.17% | +19.63% | +6.02% |
03-27 | HC Wainwright Adjusts BioAtla's Price Target to $7 From $10, Maintains Buy Rating | MT |
03-26 | Transcript : BioAtla, Inc., Q4 2023 Earnings Call, Mar 26, 2024 |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+6.02% | 122M | |
+2.16% | 42.75B | |
+47.70% | 41.61B | |
+12.27% | 41.34B | |
-8.83% | 26.59B | |
+6.50% | 25.49B | |
-22.97% | 18.12B | |
+30.28% | 12.24B | |
-2.03% | 11.76B | |
+8.72% | 11B |
- Stock Market
- Equities
- BCAB Stock
- News BioAtla, Inc.
- BioAtla : to Conduct $75 Million Private Placement of Common Stock